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A b s t r a c t  Ginkgo biloba extract (EGb 761) was adminis- 
tered orally for 4 or 6 weeks to healthy adult guinea pigs. 
Animals were then decapitated under deep ketamine anes- 
thesia. Post-mortem morphometric measurements of co- 
chlear vessels in the spiral lamina revealed a vasodilating 
effect of the extract in four of ten animals following 6 
weeks of treatment. In vivo testing of the effect of 4 or 6 
weeks of treatment with EGb 761 was monitored with 
laser Doppler flowmetry of the cochlear blood flow under 
pathological conditions. Results demonstrated that EGb 
761 partly counteracted sodium salicylate-induced decreases 
in cochlear blood flow (CBF) and enhanced CBF increases 
induced by hypoxia. These findings indicate that EGb 761 
may help to improve oxygenation in cochleas with com- 
promised blood flow. 
K e y  w o r d s  Cochlear blood flow • H y p o x i a  • O t o t o x i c i t y  - 
Laser Doppler flowmetry • Ginkgo biloba extract 
Introduction 
Cochlear microcirculation involves a complex vascular net- 
work [2] to maintain inner ear homeostasis and, more spe- 
cifically, ion and oxygen levels in the cochlear fluids. Ex- 
perimental evidence has shown that auditory function is 
highly dependent on normal cochlear metabolism [24, 26, 
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28]. Many inner ear disorders, including noise-induced 
hearing loss [12, 33, 40], some forms of sudden deafness 
[15] and presbycusis [14], are thought to be at least partly 
due to an impairment of microcirculation. Such therapeu- 
tic strategies as use of dilating drugs, hemodilution and 
CO 2 inhalation [13] have attempted to improve cochlear 
blood flow (CBF), and thus cochlear oxygenation. 
With the development of laser Doppler (LD) flowme- 
try [25, 27], dynamic measurements of CBF have yielded 
basic data on CBF regulation [5, 21, 24, 29, 34] and have 
provided an experimental basis for evaluating the effec- 
tiveness of clinical treatment [17, 20, 22,30, 31]. Further 
improvements to this experimental approach include iden- 
tification and development of animal models of vascular 
pathologies of the cochlea [8, 18, 33]. 
EGb 761 is a free radical scavenger which is prepared 
from green leaves of Ginkgo biloba trees and contains 
such flavenoids substances as ginkgo-flavone glucosides 
and ginkgolide terpenoids [9]. Experiments in the present 
study were conducted to examine the effect of EGb 761 
(Ipsen Laboratories, Paris, France) on the vasculature of 
normal guinea pig cochleas and cochleas with experimen- 
tally impaired CBE 
A first set of morphometric measurements investigated 
post-mortem vessel diameters in the stria vascularis and 
spiral lamina following long-term treatment with EGb 
761. The positive results of this study led us to set up 
complementary experiments using LD dynamic measure- 
ments of CBF in two different experimental models of 
vascular disturbances: sodium salicylate-induced decreases 
in CBF and hypoxia-induced increases in CBE 
Materials and methods 
Experimental protocols were reviewed and approved by the Uni- 
versity of Michigan's Committee on the use and care of animals. 
Morphometry 
Seventeen healty adult pigmented guinea pigs, weighing 250-350 g, 
were used. Group 1 (n = 10) received oral EGb 761 daily, at a dose 
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Table  1 Laser Doppler flowmetry: experimental groups and treat- 
ments given (+ treatment, - no treatment.) 
EGb 761 5 min hypoxia Sodium salicylate 
(100 mg/kg) (12% 02 in N) (200 mg/kg) 
Group 1 + + + 
(4 weeks) (n = 3) (n = 4) 
Group 2 + + + 
(6 weeks) (n = 4) (n = 4) 
Group 3 - + + 
(n = 3) (n = 6) 
Group 4 - - - 
(n = 4) 
of 100 mg/kg for 6 weeks. Controls (group 2, n = 7) received wa- 
ter instead of EGb 761. 
At the end of treatment, the animals of both groups were killed 
by decapitation under deep ketamine anesthesia (150 mg/kg). The 
auditory bullae were excised and quickly fixed with osmium 
tetroxide in cacodylate buffer. The stria vascularis (excluding the 
spiral l igament and prominence) and the osseous spiral lamina 
were dissected out from the first and third turns of the cochlea and 
prepared for light microscopy. The areas of the vessels were mea- 
sured in 4 -8  microscopic fields for each sample, using an image 
anatyser (Biocom, Les Ulis, France). Results were expressed as 
vascular density given by the ratio of the area of the vessels to the 
area of the measured field [4]. 
CBF LD flowmetry 
Twenty-one pigmented guinea pigs, weighing 250-350 g were 
used (Table 1). Group 1 (n = 4) was treated for 4 weeks with oral 
EGb 761 at a dose of 100 mg/kg. Group 2 (n = 4) received the 
same treatment for 6 weeks. At  the end of the treatment, animals in 
groups 1 and 2 were anesthetized, prepared for LD flowmetry (see 
below) and injected intramuscularly with freshly dissolved sodium 
salicylate in saline at a dose of 200 mg/kg. Two control groups 
were used: group 3 (n = 6) received sodium salicylate but no EGb 
761. Group 4 (n = 4) was given saline instead of sodium salicylate 
and no EGb 761. 
The same animals were used to test the effect of EGb 761 on 
the CBF response to hypoxia. Animals from group 1 (n = 3), group 
2 (n = 4) and half of group 3 (n = 3) were subjected to 5 min hy- 
poxia induced by breathing a gas mixture containing 12% oxygen 
in nitrogen prior to administration of sodium salicylate. Three ani- 
mals from group 3 were also used to check that the hypoxic episode 
did not change the subsequent response to sodium salicylate. Ani- 
mals were allowed to recover for at least 10 min following the end 
of the hypoxic period before being injected with sodium salicylate. 
After treatment with EGb 761 and before exposure to hypoxia 
and/or treatment with sodium salicylate animals were anesthetized 
with intraperitoneal sodium pentobarbital (7.5 mg/kg) and intra- 
muscular fentanyl and droperidol (Innovar-vet, Pitman-Moore, 
Mundelien, Ill., 0.2 ml/kg). One auditory bulla was surgically ex- 
posed and an LD probe (TSI, Vasamedics, St Paul, Minn.) placed 
over the bony wall of the first cochlear turn. Animals were tra- 
cheotomized and breathed freely room air or the hypoxic gas mix- 
ture delivered through a plastic tube loosely surrounding the tra- 
cheal tube. Body temperature was maintained at 38°C with a ther- 
moregulated heating pad, 
CBF and systemic blood pressure (BP) were monitored contin- 
uously and recorded on a chart recorder. The computed ratio of 
CBF to BP as cochlear whole organ vascular conductance (VC) 
was also recorded continuously. VC was used to reflect CBF 
changes not directly related to systemic BP changes. All experi- 
mental manipulations were performed after recording stable base- 
line values for CBF and BP over a 10-min period. BP and CBF 
were recorded over 90 min following the administration of sodium 
salicylate. 
Results 
M o r p h o m e t r y  
N o  d i f f e r e n c e  was  f o u n d  in  the  v a s c u l a r  d e n s i t y  o f  co-  
c h l e a r  v e s s e l s  in  t h e  s t r ia  v a s c u l a r i s  b e t w e e n  t r e a t e d  a n d  
c o n t r o l  g u i n e a  p igs  (Fig .  1A).  
In  the  sp i ra l  l a m i n a  (Fig.  1B)  n o  s t a t i s t i ca l  d i f f e r e n c e  
in  v a s c u l a r  d e n s i t y  w a s  d e m o n s t r a b l e  w h e n  c o m p a r i n g  the  
Fig. 1A, B Vascular density 
over the first and third turns of 
the cochlea in guinea pigs 
treated with EGb 761for 6 
weeks prior to sacrifice. The 
area in the box indicates the 
lower and upper limits of con- 
trol values. A Vessels of the 
stria vascularis. B Vessels of 
the spiral lamina. Symbols rep- 
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Table 2 Blood pressure ex- 
pressed as percent of baseline 
value (SD) over a 90-min ob- 
servation period following 
sodium salicylate (200 mg/kg) 
or saline administration 
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Time post-injection (min) 
5 15 30 60 90 
Group 1 
EGb 761 4 weeks+sodium 
salicylate (n = 4) 
Group 2 
EGb 761 6 weeks+sodium 
salicylate (n = 4) 
Group 3 
Sodium salicylate (n = 6) 
Group 4 
Control (saline, n = 4) 
97 (3.69) 97 (7.67) 94 (8.66) 94 (2.87) 85 (6.39) 
102 (2.21) 109 (8.53) 104 (8.65) 105 (8.98) 97.5 (13.32) 
104 (7.6) 107 (5.85) 103 (3.93) 99 (4.35) 91 (1.87) 
93 (3.26) 92 (10.81) 92 (7.63) 91 (5.59) 92 (6.94) 
i _L 
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Fig.2 Variations of vascular conductance (VC) * SD across time 
following administration of sodium salicylate (200 mg/kg i.m.) in 
animals treated with EGb 761for 4 weeks (square, group l), 6 
weeks (circle, group 2), untreated animals (diamond, group 3), and 
animals receiving saline instead of salicylate (triangle, group 4) 
mean diameter in group 2 animals versus group 1. How- 
ever, four of ten animals in group 1 showed a higher vascu- 
lar density in the first turn than the highest control value. 
The same was true for the third turn in four cases. None- 
theless, the other treated animals in this group showed 
vessel diameters within the upper range of the control val- 
ues. 
CBF responses to sodium salicylate 
Percent changes from baseline of CBF were affected by 
BP changes (Table 2). These were small over the observa- 
tion period (about 10%) and consisted mostly of a decrease 
over time that was of a similar magnitude in the different 
experimental groups. VC (i.e. the ratio CBF/BP) therefore 
mostly reflected CBF changes normalized by the small 
changes in BP inherent to the experimental preparation. 
Results are summarized in Fig. 2. In the control group 
(group 4) that received only saline, no significant varia- 
tion in measured parameters was observed post-injection. 
In group 3, which received sodium salicylate alone, a de- 
crease in CBF was observed, as previously described [8]. 
VC decreased over the first 30 min following administra- 
tion of the drug and then stabilized at about 75% of its 
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Fig.3 Variations of VC + SD across time in response to 5 min of 
hypoxia (mark along the abscissa). Animals treated with EGb 761 
for 4 weeks (circle, group 1) versus untreated animals (square, 
group 3) 
pre-treatment level. No recovery could be observed over 
the 90 min of the observation period. In groups 1 and 2 
(EGb 761-treated animals), the decrease in VC was slower 
than in group 3. Statistical significance using analysis of 
variance (ANOVA, P < 0.05) was reached in group 2 at 5, 
15 and 30 min following administration of sodium salicy- 
late when compared with findings in group 3. 
CBF responses to hypoxia 
In response to hypoxia, control animals (group 3) showed 
a systematic increase in CBF that was as much as 130% of 
baseline values despite a significant decrease in BP (of 
about 20%). As a result, VC reached values of about 60% 
above baseline (Fig. 3). In treated animals (group l), the 
increase in VC induced during the whole hypoxic period 
was slightly higher than the increase found in the controls. 
Findings in group 2 (6 weeks of EGb 761 treatment) were 
essentially similar to those observed in guinea pigs treated 
for 4 weeks (not shown). 
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Discussion 
EGb 761-induced effects on CBF response 
to sodium salicylate 
Sodium salicylate induces a reversible hearing loss in hu- 
mans, when used at medium to high doses. Its mechanism 
of toxicity has been partly clarified recently in animal 
models, showing that it causes a decrease in the LD-mea- 
sured CBF. Restoration of CBF with hydralazine as va- 
sodilator during sodium salicylate intoxication reduces 
salicylate-induced hearing loss, indicating that decreased 
CBF contributes to the hearing loss [8, 16]. In addition, 
electrophysiological and anatomical studies at an ultra- 
structural level point to the hair cells as a target of salicy- 
late toxicity through an alteration of outer hair cell ionic 
conductance [32, 36, 39]. For this reason we examined 
CBF responses to acute administrations of sodium salicy- 
late in guinea pigs chronically treated with EGb 761 as 
compared with untreated animals. 
Low oxygenation of the cochlea is also known to alter 
hearing [7, 11, 28]. Such a condition can be viewed as one 
of the most severe forms of vascular impairment in the 
cochlea. A number of studies have indirectly associated 
hypoxia with noise-induced hearing loss. Thorne and Nut- 
tall [41] showed decreased endolymphatic oxygenation 
and LD-measured CBF. Another study by Shone's group 
[37] on the aging ear showed that noise-induced tempo- 
rary and permanent threshold shifts could be eliminated 
by oxygen therapy before or during noise exposure. We 
thus produced acute short-term hypoxia and investigated 
the effect of EGb 761 on CBF responses. 
EGb 761-induced effects on vascular density 
Morphometric data showed that EGb 761 induced vasodi- 
lation of the vessels of the spiral lamina in some cases that 
was not found for vessels of the stria vascularis. This dif- 
ferential effect of the extract on the two networks of co- 
chlear vessels could possibly be related to the sympathetic 
innervation present. Indeed, anatomical investigations have 
revealed that the sympathetic fibers innervate spiral lam- 
ina vessels, radiating arterioles and venules but do not 
pass beyond the interscala septae [3, 38]. The lateral wall 
vessels also do not seem to be associated with the sympa- 
thetic innervation. Consistent with this, pharmacological 
experiments have shown that a sympatholytic drug can in- 
crease vessel diameters in the spiral lamina but not in the 
stria vascularis [6]. 
The influence of the sympathetic innervation on CBF 
is most probably vasoconstrictive, as found in pharmaco- 
logical [29] and physiological studies [21, 34]. EGb 761 
likely exerts an antagonistic action on the cochlear sym- 
pathetic nerve to the spiral lamina vessels. This is sup- 
ported by the finding that EGb 761 decreased norepineph- 
rine-induced contraction in preparations of rabbit saphe- 
nous arteries with intact endothelium [1]. In addition, EGb 
761 given intraveneously suppressed arteriolar spasm in the 
brain following topical application of autologous serum 
with normalization of the vessel diameters [35]. 
Sodium salicylate is believed to decrease CBF through its 
known inhibitory action on prostaglandin (PG) synthesis 
[42] occurring in the cochlea [10] and through increased 
levels of leukotrienes as arachidonic acid metabolites of 
the lipooxygenase pathway [16]. Our results show that the 
time course of sodium salicylate-induced decreases in CBF 
was slowed by EGb 761. Its dilating effect on the cochlear 
vessels through interaction with the sympathetic system 
was considered to partly counteract the action o f  sodium 
salicylate. This is supported by the potentiation of sodium 
salicylate ototoxicity by sympathomimetic agents [6]. In 
addition, a potentiation by EGb 761 of endothelium-de- 
rived relaxing factor (EDRF) release from endothelium 
has been shown on rabbit arteries [1]. 
Arachidonic acid metabolism through the lipooxyge- 
nase pathway probably generates free radicals [19]. Since 
increased levels of leukotrienes have been reported in the 
cochlea following salicylate administration [16], an addi- 
tional mechanism of action of EGb 761 under salicylate 
intoxication may involve its free radical scavenger prop- 
erties providing protection to endothelial ceils from dam- 
age induced by free radicals. A positive action of EGb 
761 on hearing under salicylate intoxication can also be 
inferred from a previous report [9] showing that increas- 
ing CBF by hydralazine as a dilating agent reduces salicy- 
late-induced hearing loss. 
In our animals treated with EGb 761for 6 weeks, the 
time course of the decrease in CBF in response to sodium 
salicylate was delayed, but this occurred to a lesser extent 
than in the guinea pigs treated for 4 weeks. Considering 
the variability of the response to sodium salicylate, further 
studies require the use of larger groups of animals to prove 
statistical significance. 
EGb 761-induced effects on CBF responses to hypoxia 
The increase in CBF induced in our animals by breathing 
a low oxygen mixture is very similar to the effect on CBF 
produced by carbon monoxide ventilation in the guinea 
pig [11]. This demonstrates the ability of CBF to be regu- 
lated locally, independent of systemic BP changes and 
even counteracting these by autoregulation. Oxygen mea- 
surements in the endolymph also suggest that oxygen lev- 
els are subject to some autoregulation [23]. The increased 
CBF during hypoxia probably represents a compensatory 
mechanism aimed at maintaining oxygen levels as high as 
possible. The CBF response to hypoxia then constitutes 
an experimental manipulation during which the respon- 
siveness of CBF can be assessed with its local mecha- 
nisms of regulation. In our study, EGb 761 seemed to en- 
hance this autoregulatory response while leaving the sys- 
temic BP response unchanged. This suggests that EGb 
761 can exert a local action on CBF even when given sys- 
temically. This is of importance since many other dilating 
drugs given systemically slightly increase CBF but in ac- 
tuality create a systemic hypotension [29]. 
Fechter et al. [11] reported that levels of carboxyhemo- 
globin and related hearing loss increased further than CBF 
with increasing levels of hypoxia. This led to the sugges- 
t ion of an upper  l imit  to the compensatory response. 
When  comparing the value reported by Fechter et al. with 
our unpubl ished data using higher levels of hypoxia, the 
magni tude of the increase in CBF in our study suggests 
that the compensatory response found might  be close to 
its m a x i m u m  and is brought  up to this max imum by EGb 
761 treatment, Optimal  effectiveness of EGb 761 would 
also occur for milder hypoxic levels especially since these 
are probably encountered more often in clinical practice. 
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